Similarly, high HLA-DR expression on tumor cells in laryngeal squamous cell carcinoma has been linked to better prognosis and potential response to anti-PD-1/PD-L1 therapy, possibly through increased CD4+ tumor-infiltrating lymphocytes (4). This evidence concerns the gene CD4 and neoplasm.